首页> 外文期刊>Molecular imaging and biology: MIB : the official publication of the Academy of Molecular Imaging >Fluorescence Molecular Imaging and Tomography of Matrix Metalloproteinase-Activatable Near-Infrared Fluorescence Probe and Image-Guided Orthotopic Glioma Resection
【24h】

Fluorescence Molecular Imaging and Tomography of Matrix Metalloproteinase-Activatable Near-Infrared Fluorescence Probe and Image-Guided Orthotopic Glioma Resection

机译:荧光分子成像和基质金属蛋白酶酶活性近红外荧光探针的断层扫描和图像引导的原位胶质瘤切除

获取原文
获取原文并翻译 | 示例
       

摘要

Purpose Malignant gliomas are major causes of cancer-related mortality and morbidity. Traditional surgery usually leads to incomplete resection of gliomas resulting in the high incidence of tumor recurrence. Advanced medical imaging technology, such as fluorescence imaging-guided surgery, combined with tumor-specific imaging probes allows the identification of tumor margins and improved surgery. However, there are two pressing issues that need to be addressed: first, few fluorescence imaging probes can specifically target gliomas; second, fluorescence molecular imaging (FMI) cannot get the in-depth information of deep-seated gliomas; both of which affect the complete removal of the gliomas. Procedures In this study, the biodistribution of smart matrix metalloproteinase (MMP) targeting near-infrared (NIR) fluorescent probe MMPSense 750 FAST (MMP-750) was examined in both U87MG-GFP-fLuc glioma xenograft and orthotopic mouse models using FMI. Then, CT and FMI images of orthotopic gliomas were acquired for the reconstruction of fluorescence molecular tomography (FMT) using a randomly enhanced adaptive subspace pursuit (REASP) algorithm. Furthermore, the resection of orthotopic glioma was performed using the fluorescence surgical navigation system after the injection of the MMP-750 probe. After surgery, bioluminescence imaging (BLI) and hematoxylin and eosin staining were carried out to confirm the precision resection of the tumor. Results FMI results showed that the MMP-750 probe can specifically target U87MG glioma in vivo . FMT presented the spatial information of the orthotopic glioma using the REASP reconstruction algorithm. Furthermore, MMP-750 could effectively delineate the tumor margin during glioma surgery leading to a complete resection of the tumors. Conclusions The smart MMP-750 specifically targets the glioma and FMT of MMP-750 provides 3D information for the spatial localization of the glioma. MMP-750 can work as an ideal fluorescence probe for guiding the intraoperative surgical resection of the glioma, possessing clinical translation.
机译:目的恶性胶质瘤是癌症相关死亡率和发病率的主要原因。传统手术通常导致胶质瘤的不完全切除,导致肿瘤复发发生的高发病率。先进的医学成像技术,如荧光成像引导的手术,结合肿瘤特异性成像探针,允许鉴定肿瘤余量和改善手术。然而,有两个需要解决的问题:首先,很少的荧光成像探针可以特别靶向胶质瘤;其次,荧光分子成像(FMI)不能得到深层粘性胶质瘤的深入信息;两者都影响完全去除胶质瘤。本研究中的程序,在U87MG-GFP-FLUC胶质胶质瘤异种移植物中检查靶向近红外(NIR)荧光探针MMPSENSE 750的靶向近红外(NIR)荧光探针MMPSENSE 750的生物分布。然后,使用随机增强的自适应子空间追踪(REARP)算法,获得了用于重建荧光分子断层扫描(FMT)的荧光分子断层扫描(FMT)的CT和FMI图像。此外,在注射MMP-750探针后,使用荧光手术导航系统进行原位胶质瘤的切除。进行手术后,进行生物发光成像(BLI)和苏索基蛋白和曙红染色以确认肿瘤的精确切除。结果FMI结果表明,MMP-750探针可专门针对体内靶向U87mg胶质瘤。 FMT使用REARP重建算法呈现原位胶质瘤的空间信息。此外,MMP-750可以有效地描绘胶质瘤手术期间的肿瘤余量,导致肿瘤的完全切除。结论智能MMP-750专门针对MMP-750的胶质瘤和FMT提供了胶质瘤空间定位的3D信息。 MMP-750可以作为理想的荧光探针,用于引导脊髓灰瘤的术中手术切除,具有临床翻译。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号